![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. 73581-79-0
2. Xi3rcw71nc
3. Unii-xi3rcw71nc
4. Menadionenicotinamidebisulfite
5. Einecs 277-543-7
6. Nicotinamide 2-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalene-2-sulfonate
7. 2-methyl-1,4-dioxo-3h-naphthalene-2-sulfonic Acid;pyridine-3-carboxamide
8. 2-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalene-2-sulfonic Acid; Pyridine-3-carboxamide
9. Methyl1,4-dioxo-2,3-dihydronaphthalene-2-sulfonate, Pyridine-3-carboxamide
10. 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulphonic Acid,compound With Nicotin-3-amide (1:1)
Molecular Weight | 376.4 g/mol |
---|---|
Molecular Formula | C17H16N2O6S |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 2 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 153 |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 574 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |